Start free trial
Trending New Genres Authors
EnglishEnglish
EspañolSpanish
简体中文Chinese
繁體中文Chinese (Traditional)
FrançaisFrench
DeutschGerman
日本語Japanese
PortuguêsPortuguese
ItalianoItalian
한국어Korean
РусскийRussian
NederlandsDutch
العربيةArabic
PolskiPolish
हिन्दीHindi
Tiếng ViệtVietnamese
SvenskaSwedish
ΕλληνικάGreek
TürkçeTurkish
ไทยThai
ČeštinaCzech
RomânăRomanian
MagyarHungarian
УкраїнськаUkrainian
IndonesiaIndonesian
DanskDanish
SuomiFinnish
БългарскиBulgarian
עבריתHebrew
NorskNorwegian
HrvatskiCroatian
CatalàCatalan
SlovenčinaSlovak
LietuviųLithuanian
SlovenščinaSlovenian
СрпскиSerbian
EestiEstonian
LatviešuLatvian
فارسیPersian
മലയാളംMalayalam
தமிழ்Tamil
اردوUrdu
Searching...
SoBrief
Big Chicken

Big Chicken

The Incredible Story of How Antibiotics Created Modern Agriculture and Changed the Way the World Eats
Chicken became cheap and abundant, but resistant bacteria followed it from farms to dinner tables.
by Maryn McKenna 2017 400 pages
4.19
500+ ratings
Listen
Immersive
V2.3
Amazon Kindle Audible
Try Full Access for 3 Days
Unlock listening & more!
Continue

Key Takeaways

Treat farm antibiotics as a shared public-health decision, not a barn input

A meal became an epidemic. Rick Schiller thought a fast-food dinner had made him sick. In 2013, he was hospitalized with a resistant Salmonella infection so severe that his leg swelled and his life seemed at risk. Investigators traced his illness to chicken and connected it to an outbreak that sickened 634 known people across 29 states and Puerto Rico. More than a third of those identified were hospitalized.

The consequence travels. Antibiotics used routinely in livestock select for bacteria that can survive the drugs. Those bacteria can reach people through contaminated meat, farm workers, manure, dust, and water. The central point is not that every chicken carries a dangerous infection. It is that using antibiotics to make production cheaper can create resistance beyond the farm, threatening medicines people need.

Analysis

The case makes an invisible policy choice tangible: the cost of routine drug use is not confined to the producer who benefits from it. This resembles pollution, where private gains can create diffuse public costs that no single buyer or neighbor can easily trace. The outbreak also shows why personal anecdotes matter in public health: a vivid case gives a distant statistical risk a human scale. Still, one outbreak cannot measure the total contribution of agriculture to resistance. Its force comes from being one clear link in a much larger body of evidence.

A tiny antibiotic residue helped turn chicken into cheap industrial protein

An accidental discovery scaled. In 1948, researcher Thomas Jukes fed chicks leftovers from the production of Aureomycin, an antibiotic. The heaviest group averaged 277 grams, compared with 110 grams for the control birds. The discovery suggested antibiotics could make animals grow faster on less feed. Producers quickly embraced the idea, and in 1951 the FDA approved several antibiotics for growth promotion in animal feed.

Cheapness changed the system. The drugs also helped producers manage disease risks as they crowded more animals into barns. Greater output lowered prices, while shrinking profits encouraged expansion and consolidation. What began as a way to get more weight from feed became part of the production model itself. The original gain was real, but the hidden cost was that routine exposure helped create resistant bacteria and made intensive systems easier to sustain.

Analysis

This history is a compact lesson in technological lock-in. A tool can solve the immediate problem, then reorganize an industry around the conditions that make the tool necessary. Once cheap meat, large barns, and routine medication reinforce one another, removing the drug is no longer a simple substitution. It requires redesigning the surrounding system. The discovery also illustrates why early benefits are not a complete safety case: the experiment measured weight gain, not what repeated antibiotic exposure might do to microbial populations or public health.

Breeding and contracts made the chicken boom faster, larger, and harder to reverse

The bird was redesigned. The Chicken of Tomorrow contests of the late 1940s rewarded birds that produced more meat efficiently. The winning hybrids helped replace diverse, locally adapted breeds with a small number of commercially controlled lines. A modern broiler can reach about six pounds in 47 days, compared with a 1948 contest winner that reached about three and a half pounds in 86 days. Feed needed for a pound of chicken also fell sharply.

The business was redesigned too. Companies came to control chicks, feed, processing, and sales, while contract farmers supplied buildings, labor, and debt. In the tournament system, growers are paid partly according to how their flocks perform relative to nearby farms. This rewards efficiency but leaves farmers exposed to factors such as chick quality that they may not control. The result is cheap, predictable chicken, but also concentrated power and limited room to change production independently.

Analysis

The book links biological selection to economic organization, a connection often lost when the chicken is treated as merely a food product. Breeding for speed and breast meat works especially well inside a system that rewards uniformity and scale. Yet efficiency is not neutral: it privileges measurable outputs and can make other qualities, such as hardiness, mobility, and flavor, commercially invisible. Contract farming also complicates simple accounts of producer choice. A farmer may technically operate an independent business while having little control over the major inputs or terms.

Resistance travels through bacterial communities, not just treated animals

Bacteria can share defenses. R-factors, later understood as resistance-bearing plasmids, are mobile pieces of bacterial DNA that can pass between organisms. Resistance therefore does not remain limited to the bacteria directly exposed to a drug. A harmless gut bacterium can carry resistance genes that disease-causing bacteria may acquire.

A farm experiment watched it happen. In the 1970s, researcher Stuart Levy studied chickens fed tetracycline and a nearby family. Resistant bacteria appeared in treated birds within 36 hours. Within two weeks, 90 percent of those birds carried them. The bacteria then spread to untreated chickens and to the family members working near them. The people did not become ill, but the experiment demonstrated that low-dose farm use could select resistance and move it across the farm boundary.

Analysis

The important shift is from thinking of resistance as an individual bacterium's response to seeing it as information that moves through an ecosystem. That makes the usual boundary between treated and untreated animals less reassuring. A system can create risk without immediately producing visible disease, which helps explain why early warnings were easy to dismiss. The experiment was small and controlled, so it could not estimate population-wide harm. Its value was more basic: it demonstrated a plausible route of transmission that could then be tested in real outbreaks.

Trace the food chain: resistant infections can hide in ordinary meals

An outbreak can travel far. In 1983, epidemiologists traced drug-resistant Salmonella from sick people in Minnesota back to cattle in South Dakota. The beef had moved through slaughterhouses, wholesalers, and supermarkets before reaching consumers. Some patients had taken antibiotics for unrelated infections shortly before their Salmonella symptoms appeared. Those drugs suppressed vulnerable gut bacteria, allowing the resistant Salmonella to multiply. The outbreak sickened 18 identified people, and the resistant infections were 21 times more likely to be fatal than susceptible ones.

Detection must match distribution. PulseNet compares DNA fingerprints from foodborne bacteria reported by laboratories, helping investigators connect cases scattered across many places. The system was developed after outbreaks revealed that centralized food production can distribute contamination widely before anyone sees a local cluster. In the Foster Farms outbreak, genetic matches helped link patients, chicken samples, and processing plants.

Analysis

Modern food distribution creates a mismatch: products travel quickly and broadly, while public-health investigations often begin with isolated patients. Genetic surveillance helps close that gap by identifying relationships that geography conceals. The South Dakota investigation also shows how antibiotic use can interact with medical treatment: a prescription for one infection may give a resistant organism already in the gut an opening. This does not mean patients should avoid needed antibiotics. It means prevention must address how resistance enters the food chain, not only how doctors prescribe.

Regulate before the last useful drug becomes agriculture's next cheap input

Warnings met political delay. Britain restricted some farm antibiotic uses after the 1969 Swann Report linked feed antibiotics to transferable resistance. In the United States, an FDA effort to restrict growth promoters in 1977 was blocked after industry and political opposition. Later, fluoroquinolones, valuable for serious human infections, were approved for poultry use. Resistant Campylobacter rose in people and on chicken, prompting the FDA to withdraw a poultry drug after a prolonged legal fight.

The danger can reach reserve drugs. Colistin was rarely used in human medicine because of its toxicity, but it became important against highly resistant infections. Meanwhile, it was used cheaply in livestock in some countries. In 2015, researchers identified MCR-1, a gene that could transfer colistin resistance between bacteria. By 2016 it had been detected in more than 30 countries. The lesson is to weigh shared future medical value against immediate production convenience.

Analysis

The policy history exposes a recurring institutional trap: requiring certainty about a diffuse harm before acting, while allowing the risky practice to continue generating more evidence. Precaution is not the same as banning every useful tool. It means distinguishing treatment of diagnosed illness from routine use for weight gain or blanket prevention, then monitoring whether restrictions actually reduce exposure. The Dutch experience in this book shows why labels alone can fail: when growth-promoter use was banned, farms could continue similar dosing under a preventive purpose.

Replace routine antibiotics with husbandry, not wishful thinking

Different production systems can work. France's Label Rouge program certifies slow-growing poultry raised outdoors under limits on flock and farm size. Its chickens cost more, yet account for more than three-fifths of whole chickens bought in France. The book reports Salmonella in about 3 percent of Label Rouge birds, compared with 70 percent in intensively raised French chickens.

Management can substitute for routine drugs. Dutch farmers agreed with government and industry on strict controls, including veterinarian oversight and limits on use. The country cut farm antibiotic use in half before the end of 2012, while resistant bacteria found in meat declined. Perdue's study of seven million chickens also found negligible differences in growth and mortality between flocks receiving growth promoters and those that did not. These examples suggest that hygiene, vaccination, nutrition, and careful monitoring can replace some routine use.

Analysis

These examples counter the claim that less antibiotic use necessarily means less reliable production. They also show that there is no single replacement technology: outdoor access, vaccination, sanitation, feed changes, and disciplined veterinary oversight serve different roles in different settings. The comparisons should not be read as proving that every antibiotic-free system has identical costs or can be copied everywhere. Geography, labor, consumer demand, and farm infrastructure matter. The stronger conclusion is that routine medication is not the only way to protect animal health.

Use purchasing power to make safer production commercially unavoidable

Big buyers can reset expectations. For decades, U.S. regulators struggled to curb routine farm antibiotic use. Then hospitals, schools, restaurant chains, and retailers began requiring chicken raised without routine antibiotics. Chick-fil-A announced a transition plan, followed by companies including McDonald's, Subway, Costco, and Walmart. Perdue disclosed that it had already stopped growth-promoter use and had removed human-use antibiotics from most of its chicken production.

The transition took operational work. Perdue invested in vaccines, cleaner eggs at hatcheries, revised feed, cleaner barns, and better litter management. The company found that removing antibiotics made it pay closer attention to conditions the drugs had helped mask. Buyers also had to adapt menus and sourcing so they could use more of each bird. Consumer concern mattered, but large institutional contracts gave that concern leverage across the supply chain.

Analysis

Procurement turns individual preference into coordinated demand. A shopper's choice is usually small, but a hospital network or national restaurant chain can change what producers must supply. This is a useful model for other areas where consumers lack direct control over production: standards in contracts can translate values into enforceable business requirements. Still, a label such as antibiotic-free needs clear definitions and auditing. Without transparency, marketing can outrun meaningful change, and animal health must remain protected through treatment when disease actually occurs.

Redefine a good chicken beyond weight, price, and uniformity

Antibiotics are part of a larger system. Fast-growing broilers may reach slaughter weight in weeks, but their enlarged breasts can outpace the development of legs and circulation. Farmers described birds that struggled to walk, while communities near large farms faced excess manure, odor, and runoff. In Delmarva, poultry litter carries nutrients into waterways, contributing to pollution; resistant bacteria can also leave farms through waste, dust, flies, and workers.

Better options restore other qualities. Heritage farmer Frank Reese maintains older breeds with stronger mobility and natural behaviors. At White Oak Pastures, chickens forage in fields alongside other farm animals, contributing to a rotational system, though their production costs are high and their meat is less uniform. These examples make the trade-off plain: the cheapest, most consistent bird is not automatically the best one for animals, landscapes, or eaters.

Analysis

The question of what counts as a good chicken is ultimately a question about what a food system chooses to measure. Weight, speed, and uniformity are easy to count; mobility, ecological effects, and the character of an animal's life are harder to fit into a commodity price. The book's alternatives do not erase practical limits: slower growth and hands-on processing cost more, and distinctive meat may not suit every customer. Their value is to show that the industrial standard is a choice, not a biological inevitability.

Analysis

Big Chicken is both a history of a drug and a history of an industrial design. Its central argument is not simply that antibiotics cause resistance. It shows how antibiotics, breeding, vertical integration, food marketing, and political delay became mutually reinforcing. The chicken is the narrative thread because it was the first animal in which antibiotic growth promotion became commercially compelling, and because its transformation made the model visible: a bird bred for rapid weight gain, raised in confinement, and sold as predictable protein.

The book's strongest evidentiary move is its progression from possibility to consequence. Early warnings about bacterial resistance were easy to dismiss as theoretical. Levy's farm study demonstrated movement from treated animals to people; outbreak investigations connected resistant infections to meat and farms; the colistin resistance gene exposed how agricultural use could compromise a drug that medicine had treated as a last resort. The cases do not all establish the same degree of causation, but together they make a powerful argument for treating resistance as a connected ecological problem.

The account also avoids an overly simple solution. Removing routine antibiotics can improve public health, but it does not by itself resolve concentrated ownership, farmer debt, animal welfare, or manure pollution. The contrasting farms show that transitions require practical substitutions and different market structures. Label Rouge, Dutch controls, Perdue, Bell & Evans, and White Oak Pastures do not represent one universal model. They demonstrate that production can be reorganized around different priorities, with varying costs and trade-offs.

The deepest implication is that cheap food has never been free of costs. Some costs are passed to farmers, animals, workers, neighbors, and patients who never chose the production method. Consumer demand can shift corporate behavior, but durable change requires transparent data, enforceable rules, and veterinary access for sick animals. The book's hope is not a return to an imagined past. It is the possibility of using modern knowledge without repeating the assumption that productivity alone defines progress.

Summary in 30 Seconds
Antibiotics helped chickens reach market weight faster, making industrial poultry cheap while selecting bacteria that survive treatment. Resistance can move through animals, workers, manure, water, and contaminated meat, then spread through centralized food networks. A 1970s farm study found resistance in 90 percent of treated birds within two weeks. Better hygiene, vaccination, husbandry, oversight, and buyer pressure can reduce routine use without sacrificing production.
Contains spoilers

Last updated:

Report Issue

Review Summary

4.19 out of 5
Average of 500+ ratings from Goodreads and Amazon.

Readers widely praise Big Chicken as a meticulously researched, eye-opening, and often terrifying exploration of antibiotic use in industrial poultry farming and its contribution to antimicrobial resistance. Many found it informative and engagingly written, blending personal stories with investigative journalism. Some critics noted bias, repetitiveness, or an overly U.S.-centric focus. Despite its unsettling subject matter, most appreciated its cautiously hopeful conclusion. Several reviewers reported it changed their consumption habits, while a few wished it had addressed plant-based alternatives or global perspectives more thoroughly.

Your rating:
4.7
9 ratings
Want to read the full book?

Glossary

Growth promoters

Drugs used to accelerate growth

In this book, growth promoters are antibiotics added routinely to animal feed to help livestock gain weight faster or use feed more efficiently. They are not given to treat a diagnosed infection. Their economic appeal helped make crowded, high-volume production more profitable, while selecting for bacteria resistant to the drugs.

R-factors

Transferable resistance genes

R-factors are mobile genetic elements carrying genes that make bacteria resistant to one or more antibiotics. Researchers discovered that they could move between bacteria, including organisms that had never encountered the relevant drug. The discovery explained how resistance could spread through bacterial communities rather than remaining only in the descendants of an exposed bacterium.

plasmid

Mobile bacterial DNA

A plasmid is a small, separate loop of DNA inside a bacterial cell. It can carry genes, including genes for antibiotic resistance, and may pass between bacteria as well as from a cell to its descendants. Plasmids help explain how resistance to several drugs can accumulate and spread beyond the organism first exposed to an antibiotic.

PulseNet

Foodborne outbreak fingerprint network

PulseNet is a public-health network that compares DNA fingerprints from foodborne bacteria collected from patients. When matching patterns appear in people far apart, investigators can recognize a possible shared outbreak and search for its food source. The system helps track contamination in a food supply where products may be processed centrally and distributed across many regions.

ExPEC

Extraintestinal pathogenic E. coli

ExPEC means extraintestinal pathogenic Escherichia coli. These strains can cause infections outside the intestine, including urinary tract, kidney, bloodstream, and other infections. The book describes evidence linking resistant ExPEC strains in people to strains found on poultry and other foods, making some common infections part of a broader food-system concern.

Label Rouge

French certified poultry system

Label Rouge is a French certification program for poultry raised under defined production standards. Its rules include slow-growing breeds, outdoor access, limits on flock and housing scale, and no routine antibiotic use. Certification and inspection support a market for birds with different flavor and texture from standard industrial chicken, sold at a higher price.

tournament system

Relative-performance grower pay

The tournament system is a contract arrangement in which poultry growers' pay depends partly on how efficiently their flocks perform compared with nearby growers. Measures include bird weight gain relative to feed consumed. The system can reward efficient production, but farmers may be penalized for factors outside their control, such as the condition of chicks supplied to them.

animal defined daily dose

Farm antibiotic-use measure

The animal defined daily dose is a measure used in the Netherlands to compare antibiotic use across farms raising similar animals. It estimates how many days in a year animals receive antibiotics. The measure lets regulators and producers benchmark farms, set targets, and identify high use, rather than relying only on total drug sales.

About the Author

Maryn McKenna is an accomplished journalist and author specializing in public health, global health, and food policy. She has reported from epidemics, disasters, and food production sites across multiple continents, covering events ranging from Hurricane Katrina to the 2015 avian flu outbreak. Her work appears in major publications including The New York Times Magazine, National Geographic, Wired, and The Atlantic. She is the award-winning author of Superbug and Beating Back the Devil, a Senior Fellow at Brandeis University's Schuster Institute for Investigative Journalism, and her 2015 TED talk on antibiotic resistance has surpassed 1.5 million views.

Download PDF

To save this Big Chicken summary for later, download the free PDF. You can print it out, or read offline at your convenience.
Download PDF
File size: 0.27 MB     Pages: 15

Download EPUB

To read this Big Chicken summary on your e-reader device or app, download the free EPUB. The .epub digital book format is ideal for reading ebooks on phones, tablets, and e-readers.
Download EPUB
File size: 1.26 MB     Pages: 19
Want to read the full book?
Follow
Listen
Home
Swipe
Library
Get App
Try Full Access for 3 Days
Listen, bookmark, and more
Compare Features Free Pro
📖 Read Summaries
Read unlimited summaries. Free users get 3 per month
🎧 Listen to Summaries
Listen to unlimited summaries in 40 languages
—
❤️ Unlimited Bookmarks
Free users are limited to 4
—
📜 Unlimited History
Free users are limited to 4
—
📥 Unlimited Downloads
Free users are limited to 1
—
Risk-Free Timeline
Today: Get Instant Access
Listen to full summaries of 26,000+ books. That's 12,000+ hours of audio!
Day 2: Trial Reminder
We'll send you a notification that your trial is ending soon.
Day 3: Your subscription begins
You'll be charged on Nov 24,
cancel anytime before.
Consume 2.8× More Books
2.8× more books Listening Reading
Our users love us
1M+ readers
Trustpilot Rating
TrustPilot
4.6 Excellent
This site is a total game-changer. I've been flying through book summaries like never before. Highly, highly recommend.
— Dave G
Worth my money and time, and really well made. I've never seen this quality of summaries on other websites. Very helpful!
— Em
Highly recommended!! Fantastic service. Perfect for those that want a little more than a teaser but not all the intricate details of a full audio book.
— Greg M
Save 62%
Yearly
$119.88 $44.99/year/yr
$3.75/mo
Monthly
$9.99/mo
Start a 3-Day Free Trial
3 days free, then $44.99/year. Cancel anytime.
Unlock a world of fiction & nonfiction books
26,000+ books for the price of 2 books
Read any book in 10 minutes
Discover new books like Tinder
Request any book if it's not summarized
Read more books than anyone you know
#1 app for book lovers
Lifelike & immersive summaries
30-day money-back guarantee
Download summaries in EPUBs or PDFs
Cancel anytime in a few clicks

Why one summary?

Scanner
Find a barcode to scan

⭐
⭐
⭐
We have a special gift for you
Open
38% off
DISCOUNT FOR YOU
⭐
⭐
⭐
$79.99
$49.99/year
Only $4.16 per month
Continue
2 taps to start, super easy to cancel
Settings
General
Widget
Loading...